Welcome to the Arkansas Medicaid Portal

This website address is now ar.primetherapeutics.com. Starting Dec 2, the redirect will be disabled, and old bookmarks will not function. Any saved bookmarks for this page should be updated to ar.primetherapeutics.com.

Some website links embedded in older documents may not work as expected after Dec. 1, 2024. If you have questions about a document or page, please contact us.

Effective August 1, 2024, Arkansas Medicaid will begin accepting Pharmacy and DME claims for diabetic supplies through the Pharmacy Program. AR Medicaid Pharmacy providers who are filling diabetic supply prescriptions may continue to use their current Point-of-Sale (POS) system. DME providers must register and bill through the new portal via web claim submissions. We encourage DME Providers to register as soon as possible. For more information on this process, see the Web Claims Submission Guide. This program applies to traditional FFS Medicaid members, including ARKids B. This program does not apply to members with dual Medicare/Medicaid or those managed in the ARHome program by a QHP.

Arkansas Medicaid has updated the prior authorization criteria for Hepatitis C reviews. The requirement for a certain fibrosis score, which dictates the amount of fibrosis in the liver, has been removed from the criteria. Fibrosis scores will no longer determine treatment eligibility. In addition, sobriety for at least 6 months prior to the requested treatment is no longer applicable.  All prior authorization requests received will continue to be reviewed on a case-by-case basis.